Factores relacionados con éxito de la inyección intracitoplasmática de espermatozoides y criotransfer en una clínica de Bogotá

Este estudio explora la relación entre determinados factores de tipo socio demográfico, clínico y paraclínico con los resultados del tratamiento de inyección intracitoplasmática de semen /fertilización in vitro (FIV/ICSI) y crio transferencia de embriones, en una institución especializada en tratami...

Descripción completa

Detalles Bibliográficos
Autor Principal: Velandia Toro, Pedro
Otros Autores: Madero Cervera, Jose Ignacio
Formato: Tesis de maestría (Master Thesis)
Lenguaje:Español (Spanish)
Publicado: Universidad del Rosario 2017
Materias:
Acceso en línea:http://repository.urosario.edu.co/handle/10336/13370
id ir-10336-13370
recordtype dspace
institution EdocUR - Universidad del Rosario
collection DSpace
language Español (Spanish)
topic Inyección intracioplasmática de semen
Infertilidad
Embarazo bioquímico
Fertilización in vitro
Criotransferencia de embriones
Enfermedades
Endocrinología
Intracytoplasmic semen injection
In vitro fertilization
Biochemical Pregnancy
Infertility
Endocrinología
Aborto
Embarazo
Inducción embrionaria
Infertilidad
spellingShingle Inyección intracioplasmática de semen
Infertilidad
Embarazo bioquímico
Fertilización in vitro
Criotransferencia de embriones
Enfermedades
Endocrinología
Intracytoplasmic semen injection
In vitro fertilization
Biochemical Pregnancy
Infertility
Endocrinología
Aborto
Embarazo
Inducción embrionaria
Infertilidad
Velandia Toro, Pedro
Factores relacionados con éxito de la inyección intracitoplasmática de espermatozoides y criotransfer en una clínica de Bogotá
description Este estudio explora la relación entre determinados factores de tipo socio demográfico, clínico y paraclínico con los resultados del tratamiento de inyección intracitoplasmática de semen /fertilización in vitro (FIV/ICSI) y crio transferencia de embriones, en una institución especializada en tratamientos de fertilidad; en razón a que este tipo de tratamientos acarrean consigo un valor emocional, social y económico significativo dentro de la dinámica del derecho individual y de la pareja de la reproducción, y de la estructuración de una familia. Se realizó mediante la sustracción de datos clínicos y paraclínicos de manera retrospectiva de las historias clínicas disponibles, para un posterior análisis estadístico de la relación con el desenlace duro como es el embarazo químico, con los parámetros considerados como principalmente relacionados a nivel internacional, para la valoración de éxito de este tipo de tratamientos. Dentro de los parámetros que se analizaran para la búsqueda de relaciones están: Edad materna, Índice de masa corporal, exposición a tóxicos, estatus gestacional, numero de tratamientos de ICSI y fertilización in vitro previos, tipo de infertilidad, conteo folicular antral, valor de hormona antimulleriana pretratamiento, tipo de protocolo de estimulación ovárica, entre otros. Todos parámetros que han sido debatidos en la literatura como de relevancia para el análisis de tratamientos de fertilidad.
author2 Madero Cervera, Jose Ignacio
author_facet Madero Cervera, Jose Ignacio
Velandia Toro, Pedro
format Tesis de maestría (Master Thesis)
author Velandia Toro, Pedro
author_sort Velandia Toro, Pedro
title Factores relacionados con éxito de la inyección intracitoplasmática de espermatozoides y criotransfer en una clínica de Bogotá
title_short Factores relacionados con éxito de la inyección intracitoplasmática de espermatozoides y criotransfer en una clínica de Bogotá
title_full Factores relacionados con éxito de la inyección intracitoplasmática de espermatozoides y criotransfer en una clínica de Bogotá
title_fullStr Factores relacionados con éxito de la inyección intracitoplasmática de espermatozoides y criotransfer en una clínica de Bogotá
title_full_unstemmed Factores relacionados con éxito de la inyección intracitoplasmática de espermatozoides y criotransfer en una clínica de Bogotá
title_sort factores relacionados con éxito de la inyección intracitoplasmática de espermatozoides y criotransfer en una clínica de bogotá
publisher Universidad del Rosario
publishDate 2017
url http://repository.urosario.edu.co/handle/10336/13370
_version_ 1694382550470885376
spelling ir-10336-133702021-03-01T19:22:49Z Factores relacionados con éxito de la inyección intracitoplasmática de espermatozoides y criotransfer en una clínica de Bogotá Velandia Toro, Pedro Madero Cervera, Jose Ignacio Buitrago-Medina, Daniel-Alejandro Inyección intracioplasmática de semen Infertilidad Embarazo bioquímico Fertilización in vitro Criotransferencia de embriones Enfermedades Endocrinología Intracytoplasmic semen injection In vitro fertilization Biochemical Pregnancy Infertility Endocrinología Aborto Embarazo Inducción embrionaria Infertilidad Este estudio explora la relación entre determinados factores de tipo socio demográfico, clínico y paraclínico con los resultados del tratamiento de inyección intracitoplasmática de semen /fertilización in vitro (FIV/ICSI) y crio transferencia de embriones, en una institución especializada en tratamientos de fertilidad; en razón a que este tipo de tratamientos acarrean consigo un valor emocional, social y económico significativo dentro de la dinámica del derecho individual y de la pareja de la reproducción, y de la estructuración de una familia. Se realizó mediante la sustracción de datos clínicos y paraclínicos de manera retrospectiva de las historias clínicas disponibles, para un posterior análisis estadístico de la relación con el desenlace duro como es el embarazo químico, con los parámetros considerados como principalmente relacionados a nivel internacional, para la valoración de éxito de este tipo de tratamientos. Dentro de los parámetros que se analizaran para la búsqueda de relaciones están: Edad materna, Índice de masa corporal, exposición a tóxicos, estatus gestacional, numero de tratamientos de ICSI y fertilización in vitro previos, tipo de infertilidad, conteo folicular antral, valor de hormona antimulleriana pretratamiento, tipo de protocolo de estimulación ovárica, entre otros. Todos parámetros que han sido debatidos en la literatura como de relevancia para el análisis de tratamientos de fertilidad. This study explores the relationship between certain sociodemographic, clinical and paraclinical factors with the results of intracytoplasmic injection of semen / in vitro fertilization (IVF / ICSI) and cryo embryo transfer, in an institution specialized in fertility treatments; Because this type of treatment carries with it significant emotional, social and economic value within the dynamics of the individual right and the reproduction couple, and the structuring of a family. It was done by subtracting clinical and paraclinical data retrospectively from the available clinical histories, for a subsequent statistical analysis of the relationship with the hard outcome such as chemical pregnancy, with the parameters considered mainly related at international level, for the Evaluation of success of this type of treatments. Among the parameters to be analyzed for the search for relationships are: Maternal age, Body mass index, exposure to toxicants, gestational status, number of previous ICSI treatments and in vitro fertilization, type of infertility, antral follicular count, Antimullerian hormone pretreatment, type of ovarian stimulation protocol, among others. All parameters that have been debated in the literature as of relevance for the analysis of fertility treatments. 2017-05-10 2017-05-12T11:58:31Z info:eu-repo/semantics/masterThesis info:eu-repo/semantics/acceptedVersion http://repository.urosario.edu.co/handle/10336/13370 spa info:eu-repo/semantics/openAccess application/pdf Universidad del Rosario Facultad de medicina instname:Universidad del Rosario reponame:Repositorio Institucional EdocUR Tarducci, M. (2008). Maternidades en el siglo XXI. In Publicación científica y técnica (Vol. 614). Espacio Editorial. Gurtcheff, S. E., & Klein, N. A. (2011). Diminished ovarian reserve and infertility. Clinical obstetrics and gynecology, 54(4), 666-674. Zarek, S. M., Mitchell, E. M., Sjaarda, L. A., Mumford, S. L., Silver, R. M., Stanford, J. B., ... & Schisterman, E. F. (2015). Is anti-Müllerian hormone associated with fecundability? Findings from the EAGeR trial. The Journal of Clinical Endocrinology & Metabolism, 100(11), 4215-4221. Barbakadze, L., Kristesashvili, J., Khonelidze, N., & Tsagareishvili, G. (2015). The correlations of anti-mullerian hormone, follicle-stimulating hormone and antral follicle count in different age groups of infertile women. International journal of fertility & sterility, 8(4), 393. Tal, R., Tal, O., Seifer, B. J., & Seifer, D. B. (2015). Antimüllerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis. Fertility and sterility, 103(1), 119-130. Steptoe, P. C., & Edwards, R. G. (1978). Birth after the reimplantation of a human embryo. The Lancet, 312(8085), 366) Calhaz-Jorge, C., de Geyter, C., Kupka, M. S., de Mouzon, J., Erb, K., Mocanu, E. (2016). Assisted reproductive technology in Europe, 2012: results generated from European registers by ESHRE. Human Reproduction. Green, N. S. (2004). Risks of birth defects and other adverse outcomes associated with assisted reproductive technology. Pediatrics, 114(1), 256-259. American Society for Reproductive Medicine. Ovarian hyperstimulation syndrome. Fertil Steril 2006;86:S178–836. Macaluso, M., Wright-Schnapp, T. J., Chandra, A., Johnson, R., Satterwhite, C. L., Pulver, A., ... & Pollack, L. A. (2010). A public health focus on infertility prevention, detection, and management. Fertility and sterility, 93(1), 16-e1. National, Regional, and Global Trends in Infertility Prevalence Since 1990: A Systematic Analysis of 277 Health Surveys. Van Steirteghem, A. C., Nagy, Z., Joris, H., Liu, J., Staessen, C., Smitz, J., ... & Devroey, P. (1993). High fertilization and implantation rates after intracytoplasmic sperm injection. Human Reproduction, 8(7), 1061-1066. Huszar, G., Ozenci, C. C., Cayli, S., Zavaczki, Z., Hansch, E., & Vigue, L. (2003). Hyaluronic acid binding by human sperm indicates cellular maturity, viability, and unreacted acrosomal status. Fertility and Sterility, 79, 1616-1624 Parmegiani, L., Cognigni, G. E., Bernardi, S., Troilo, E., Ciampaglia, W., & Filicori, M. (2010). “Physiologic ICSI”: hyaluronic acid (HA) favors selection of spermatozoa without DNA fragmentation and with normal nucleus, resulting in improvement of embryo quality. Fertility and sterility, 93(2), 598-604 Jakab, A., Sakkas, D., Delpiano, E., Cayli, S., Kovanci, E., Ward, D., ... & Huszar, G. (2005). Intracytoplasmic sperm injection: a novel selection method for sperm with normal frequency of chromosomal aneuploidies. Fertility and sterility, 84(6), 1665- 1673 Balaban, B., Lundin, K., Morrell, J. M., Tjellström, H., Urman, B., & Holmes, P. V. (2003). An alternative to PVP for slowing sperm prior to ICSI. Human Reproduction, 18(9), 1887-1889. Mantikou, E., Youssef, M. A., van Wely, M., van der Veen, F., Al-Inany, H. G., Repping, S., & Mastenbroek, S. (2013). Embryo culture media and IVF/ICSI success rates: a systematic review. Human reproduction update, 19(3), 210-220. Barak, Y., Menezo, Y., Veiga, A., & Elder, K. (2001). A physiological replacement for polyvinylpyrrolidone (PVP) in assisted reproductive technology. Human Fertility, 4(2), 99-103. Jean, M., Mirallié, S., Boudineau, M., Tatin, C., & Barrière, P. (2001). Intracytoplasmic sperm injection with polyvinylpyrrolidone: a potential risk. Fertility and sterility, 76(2), 419-420. Parmegiani, L., Cognigni, G. E., Bernardi, S., Troilo, E., Taraborrelli, S., Arnone, A., ... & Filicori, M. (2012). Comparison of two ready-to-use systems designed for sperm–hyaluronic acid binding selection before intracytoplasmic sperm injection: PICSI vs. Sperm Slow: a prospective, randomized trial. Fertility and sterility, 98(3), 632-637. Ménézo, Y., & Nicollet, B. (2004, May). Replacement of PVP by hyaluronate (SpermSlow™) in ICSI—Impact on outcome. In 2004 Abstract of 18th World Congress on Fertility and Sterility IFFS Nasr-Esfahani, M. H., Razavi, S. H. A. H. N. A. Z., Vahdati, A. A., Fathi, F., & Tavalaee, M. (2008). Evaluation of sperm selection procedure based on hyaluronic acid binding ability on ICSI outcome. Journal of assisted reproduction and genetics, 25(5), 197-203. Palermo, G., Joris, H., Devroey, P., & Van Steirteghem, A. C. (1992). Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. The Lancet, 340(8810), 17-18. Cummins, J. M., Breen, T. M., Harrison, K. L., Shaw, J. M., Wilson, L. M., & Hennessey, J. F. (1986). A formula for scoring human embryo growth rates in in vitro fertilization: its value in predicting pregnancy and in comparison, with visual estimates of embryo quality. Journal of In Vitro Fertilization and Embryo Transfer, 3(5), 284-295 Steer CV, Mills CL, Tan SL, Campbell S & Edwards RG (1992) The cumulativeembryo score: a predictive embryo scoring technique to select the optimal number ofembryos to transfer in an in-vitro fertilization and embryo transfer programme. HumReprod 7(1):117–119. Bertrand, E., Van den Bergh, M., & Englert, Y. (1995). Fertilization and early embryology: Does zona pellucida thickness influence the fertilization rate?. Human reproduction, 10(5), 1189-1193. Shoukir, Y., Campana, A., Farley, T., & Sakkas, D. (1997). Early cleavage of in-vitro fertilized human embryos to the 2-cell stage: a novel indicator of embryo quality and viability. Human Reproduction, 12(7), 1531-1536 Blake, D., Proctor, M., Johnson, N., & Olive, D. (2002). Cleavage stage versus blastocyst stage embryo transfer in assisted conception. The Cochrane Library. Angell RR, Aitken RJ, van Look PF, Lumsden MA & Templeton AA (1983) Chromosome abnormalities in human embryos after in vitro fertilization. Nature 303(5915): 336–338 Shahine LK & Cedars MI (2006) Preimplantation genetic diagnosis does not increase pregnancy rates in patients at risk for aneuploidy. Fertil Steril 85(1): 51 – 6. Munne S, Lee A, Rosenwaks Z, Grifo J & Cohen J (1993) Diagnosis of major chromosome aneuploidies in human preimplantation embryos. Hum Reprod 8(12): 2185–2191. Moutou C, Gardes N & Viville S (2004) Duplex, triplex and quadruplex PCR for the preimplantation genetic diagnosis (PGD) of cystic fibrosis (CF), an exhaustive approach. Prenat Diagn 24(7): 62–69. Sermon K, De Rijcke M, Lissens W, De Vos A, Platteau P, Bonduelle M et al. (2002) Preimplantation genetic diagnosis for Huntington's disease with exclusion testing. Eur J Hum Genet 10(10): 591–598. Rogers PA, Milne BJ & Trounson AO (1986) A model to show human uterine receptivity and embryo viability following ovarian stimulation for in vitro fertilization. J In Vitro Fert Embryo Transf 3(2):93–98. Zuckerman, S. (1951). The number of oocytes in the mature ovary. Recent Progress in Hormone Research, 6, 63-109 Faddy MJ, Gosden RG, Gougeon A, Richardson SJ & Nelson JF (1992) Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod 7(10): 1342–1346 Hassold TJ & Jacobs PA (1984) Trisomy in man. Annu Rev Genet 18: 69–97, Sherman SL, Freeman SB, Allen EG & Lamb NE (2005) Risk factors for nondisjunction of trisomy 21. Cytogenet Genome Res 111(3–4): 273–280. Keay SD, Liversedge NH, Mathur RS, Jenkins JM (1997) Assisted conception following poor ovarian response to gonadotrophin stimulation. Br J Obstet Gynaecol 104(5): 521–527. Zaadstra BM, Seidell JC, Van Noord PA, te Velde ER, Habbema JD, Vrieswijk B, et al. (1993) Fat and female fecundity: prospective study of effect of body fat distribution on conception rates. BMJ 306(6876): 484–487– 238 Frisch RE (1987) Body fat, menarche, fitness and fertility. Hum Reprod 2(6): 521– 533. Schweiger U, Laessle R, Pfister H, Hoehl C, Schwingenschloegel M, Schweiger M et al. (1987) Diet-induced menstrual irregularities: effects of age and weight loss. Fertil Steril 48(5): 746–751. Maconochie N, Doyle P, Prior S & Simmons R (2007) Risk factors for first trimester miscarriage — results from a UK-population-based case-control study. BJOG 114(2): 170–186. Abdel Raheem, A., Rushwan, N., Garaffa, G., Zacharakis, E., Doshi, A., Heath, C., ... & Ralph, D. (2013). Factors influencing intracytoplasmic sperm injection (ICSI) outcome in men with azoospermia. BJU international, 112(2), 258-264 Zarinara, A., Zeraati, H., Kamali, K., Mohammad, K., Shahnazari, P., & Akhondi, M. M. (2016). Models predicting success of infertility treatment: A systematic review. Journal of reproduction & infertility, 17(2), 68). Steptoe, P. C., & Edwards, R. G. (1978). Birth after the reimplantation of a human embryo. The Lancet, 312(8085), 366). Van Loendersloot, L. L., Van Wely, M., Limpens, J., Bossuyt, P. M. M., Repping, S., & Van Der Veen, F. (2010). Predictive factors in in vitro fertilization (IVF): a systematic review and meta-analysis. Human reproduction update. Strandell, A., Bergh, C., & Lundin, K. (2000). Selection of patients suitable for oneembryo transfer may reduce the rate of multiple births by half without impairment of overall birth rates. Human Reproduction, 15(12), 2520-2525. El-Toukhy, T., Khalaf, Y., Hart, R., Taylor, A., & Braude, P. (2002). Young age does not protect against the adverse effects of reduced ovarian reserve—an eight year study. Human Reproduction, 17(6), 1519-1524. Hunault, C. C., Eijkemans, M. J., Pieters, M. H., te Velde, E. R., Habbema, J. D. F., Fauser, B. C., & Macklon, N. S. (2002). A prediction model for selecting patients undergoing in vitro fertilization for elective single embryo transfer. Fertility and sterility, 77(4), 725-732. Van der Gaast, M. H., Eijkemans, M. J. C., Van der Net, J. B., De Boer, E. J., Burger, C. W., Van Leeuwen, F. E., ... & Macklon, N. S. (2006). Optimum number of oocytes for a successful first IVF treatment cycle. Reproductive biomedicine online, 13(4), 476-480. Strassburger, D., Friedler, S., Raziel, A., Kasterstein, E., Schachter, M., & Ron‐El, R. (2004). The outcome of ICSI of immature MI oocytes and rescued in vitro matured MII oocytes. Human Reproduction, 19(7), 1587-1590. Cai, Q. F., Wan, F., Huang, R., & Zhang, H. W. (2011). Factors predicting the cumulative outcome of IVF/ICSI treatment: a multivariable analysis of 2450 patients. Human reproduction, 26(9), 2532-2540. Al-Ghazali, B. S., Al-Bderi, A. J., & Mubark, A. M. (2015). Factors Affecting Pregnancy Outcome in Subfertile Couples Subjected to Intracytoplasmic Sperm Injection. Kufa Journal for Nursing Sciences, 4(3). La Marca, A., et al. "Anti-Müllerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)." Human reproduction update 16.2 (2010): 113-130. Dewailly, D., Andersen, C. Y., Balen, A., Broekmans, F., Dilaver, N., Fanchin, R., ... & Mason, H. (2014). The physiology and clinical utility of anti-Müllerian hormone in women. Human reproduction update, 20(3), 370-385. La Marca, A., Stabile, G., Artenisio, A. C., & Volpe, A. (2006). Serum anti-Mullerian hormone throughout the human menstrual cycle. Human Reproduction, 21(12), 3103-3107. Bentzen, J. G., Forman, J. L., Pinborg, A., Lidegaard, Ø., Larsen, E. C., Friis-Hansen, L., ... & Andersen, A. N. (2012). Ovarian reserve parameters: a comparison between users and non-users of hormonal contraception. Reproductive biomedicine online, 25(6), 612-619. Kallio, S., Puurunen, J., Ruokonen, A., Vaskivuo, T., Piltonen, T., & Tapanainen, J. S. (2013). Antimüllerian hormone levels decrease in women using combined contraception independently of administration route. Fertility and sterility, 99(5), 1305-1310 Chan, C., & Liu, K. (2014). Clinical pregnancy in a woman with idiopathic hypogonadotropic hypogonadism and low AMH: utility of ovarian reserve markers in IHH. Journal of assisted reproduction and genetics, 31(10), 1317-1321 Pigny, P., Merlen, E., Robert, Y., Cortet-Rudelli, C., Decanter, C., Jonard, S., & Dewailly, D. (2003). Elevated serum level of anti-mullerian hormone in patients with 83 polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. The Journal of Clinical Endocrinology & Metabolism, 88(12), 5957- 5962 Pellatt, Laura, Suman Rice, and Helen D. Mason. "Anti-Müllerian hormone and polycystic ovary syndrome: a mountain too high?." Reproduction 139.5 (2010): 825- 833. Seifer, David B., and David T. MacLaughlin. "Mullerian Inhibiting Substance is an ovarian growth factor of emerging clinical significance." Fertility and sterility 88.3 (2007): 539-546 , Nelson, Scott M., et al. "Anti-Müllerian hormone: clairvoyance or crystal clear?." Human Reproduction 27.3 (2012): 631-636. La Marca, A., et al. "Anti-Müllerian hormone concentrations in maternal serum during pregnancy." Human Reproduction 20.6 (2005): 1569-1572. de Vet, Annemarie, et al. "Antimüllerian hormone serum levels: a putative marker for ovarian aging." Fertility and sterility 77.2 (2002): 357-362. Broer, S. L., et al. "AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis." Human reproduction update 17.1 (2011): 46-54 Levi, Andrew J., et al. "Reproductive outcome in patients with diminished ovarian reserve." Fertility and sterility 76.4 (2001): 666-669). Faddy, M. J., and R. G. Gosden. "Physiology: A mathematical model of follicle dynamics in the human ovary." Human Reproduction 10.4 (1995): 770-775 Toner, James P., et al. "Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age." Fertility and sterility55.4 (1991): 784- 791) Seifer, David B., et al. "Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome." Fertility and sterility 67.1 (1997): 110-114. Lekamge, Dharmawijaya N., et al. "Anti-Müllerian hormone as a predictor of IVF outcome." Reproductive biomedicine online 14.5 (2007): 602-610. Nelson, Scott M., Robin W. Yates, and Richard Fleming. "Serum anti-Müllerian hormone and FSH: prediction of live birth and extremes of response in stimulated 84 cycles - implications for individualization of therapy." Human Reproduction 22.9 (2007): 2414-2421. Fanchin, Renato, et al. "Anti-Mullerian hormone concentrations in the follicular fluid of the preovulatory follicle are predictive of the implantation potential of the ensuing embryo obtained by in vitro fertilization." The Journal of Clinical Endocrinology & Metabolism 92.5 (2007): 1796-1802. Silberstein, T., et al. "Müllerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology." Human Reproduction 21.1 (2006): 159-163). Iliodromiti, Stamatina, et al. "The predictive accuracy of anti-Müllerian hormone for live birth after assisted conception: a systematic review and meta-analysis of the literature." Human reproduction update (2014). Broer, Simone L., et al. "Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach." Human reproduction update 19.1 (2013): 26-36). Tal, Reshef, et al. "Antimüllerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis." Fertility and sterility 103.1 (2015): 119-130. Brodin, Thomas, et al. "Antimüllerian hormone levels are strongly associated with live-birth rates after assisted reproduction." The Journal of Clinical Endocrinology & Metabolism 98.3 (2013): 1107-1114. Irez, Tulay, et al. "Different serum anti-Müllerian hormone concentrations are associated with oocyte quality, embryo development parameters and IVF-ICSI outcomes." Archives of gynecology and obstetrics 284.5 (2011): 1295-1301. Kaya, Cemil, Recai Pabuccu, and Hakan Satıroglu. "Serum antimüllerian hormone concentrations on day 3 of the in vitro fertilization stimulation cycle are predictive of the fertilization, implantation, and pregnancy in polycystic ovary syndrome patients undergoing assisted reproduction." Fertility and sterility 94.6 (2010): 2202-2207. Seifer, David B., et al. "Variations in serum müllerian inhibiting substance between white, black,and Hispanic women." Fertility and sterility 92.5 (2009): 1674-1678. Ebner, T., Sommergruber, M., Moser, M., Shebl, O., Schreier-Lechner, E., & Tews, G. (2006). Basal level of anti-Müllerian hormone is associated with oocyte quality in stimulated cycles. Human reproduction, 21(8), 2022-2026. Eldar-Geva, T., Ben-Chetrit, A., Spitz, I. M., Rabinowitz, R., Markowitz, E., Mimoni, T., ... & Margalioth, E. J. (2005). Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome. Human reproduction, 20(11), 3178-318. Penarrubia, J., Fábregues, F., Manau, D., Creus, M., Casals, G., Casamitjana, R., ... & Balasch, J. (2005). Basal and stimulation day 5 anti-Müllerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist–gonadotropin treatment. Human Reproduction, 20(4), 915-922. Tremellen, K. P., Kolo, M., Gilmore, A., & Lekamge, D. N. (2005). Anti‐müllerian hormone as a marker of ovarian reserve. Australian and New Zealand Journal of Obstetrics and Gynaecology, 45(1), 20-24. Hansen, K. R., Hodnett, G. M., Knowlton, N., & Craig, L. B. (2011). Correlation of ovarian reserve tests with histologically determined primordial follicle number. Fertility and sterility, 95(1), 170-175. La Marca, A., & Sunkara, S. K. (2014). Reply: The two sides of the individualization of controlled ovarian stimulation. Human reproduction update, 20(4), 614-615. Silva, G. M. D., Diniz, A. L. D., Bernardino Neto, M., Marcolini, T. T., Perillo, L. C. A., Pires, W. D. P., & Pessoa, S. M. (2014). Number of antral follicles and the success of in vitro fertilization: a multivariate analysis. Revista Brasileira de Ginecologia e Obstetrícia, 36(10), 473-479. Broekmans, F. J., de Ziegler, D., Howles, C. M., Gougeon, A., Trew, G., & Olivennes, F. (2010). The antral follicle count: practical recommendations for better standardization. Fertility and sterility, 94(3), 1044-1051. Verma, I., Sood, R., Juneja, S., & Kaur, S. (2012). Prevalence of hypothyroidism in infertile women and evaluation of response of treatment for hypothyroidism on infertility. International Journal of Applied and Basic Medical Research, 2(1), 17– 19. Cabrera, S. M., Bright, G. M., Frane, J. W., Blethen, S. L., & Lee, P. A. (2014). Age of thelarche and menarche in contemporary US females: a cross-sectional analysis. Journal of Pediatric Endocrinology & Metabolism : JPEM, 27(0), 47–51. http://doi.org/10.1515/jpem-2013-0286 Bellver, J., Ayllón, Y., Ferrando, M., Melo, M., Goyri, E., Pellicer, A., ... & Meseguer, M. (2010). Female obesity impairs in vitro fertilization outcome without affecting embryo quality. Fertility and sterility, 93(2), 447-454. De los Santos, M. J., Apter, S., Coticchio, G., Debrock, S., Lundin, K., Plancha, C. E., ... & Vermeulen, N. (2016). Revised guidelines for good practice in IVF laboratories (2015). Human Reproduction, 31(4), 685-686. Mark P. J. Vanderpump; The epidemiology of thyroid disease. Br Med Bull 2011; 99 (1): 39-51 De Vries, M. J., De Sutter, P., & Dhont, M. (1999). Prognostic factors in patients continuing in vitro fertilization or intracytoplasmic sperm injection treatment and dropouts. Fertility and sterility, 72(4), 674-678. Perin, P. M., Maluf, M., Czeresnia, C. E., Januário, D. A. N. F., & Saldiva, P. H. N. (2010). Impact of short-term preconceptional exposure to particulate air pollution on treatment outcome in couples undergoing in vitro fertilization and embryo transfer (IVF/ET). Journal of assisted reproduction and genetics, 27(7), 371-382. Aguinaga del Hierro, M. J. (2014). Factores pronósticos de éxito o fracaso para fertilización in vitro en pacientes de la clínica INFES desde enero del 2007 hasta diciembre del 2012. Bulletti, C., Coccia, M. E., Battistoni, S., & Borini, A. (2010). Endometriosis and infertility. Journal of assisted reproduction and genetics, 27(8), 441-447. Terriou, P., Sapin, C., Giorgetti, C., Hans, E., Spach, J. L., & Roulier, R. (2001). Embryo score is a better predictor of pregnancy than the number of transferred embryos or female age. Fertility and sterility, 75(3), 525-531. Windt, M. L., Kruger, T. F., Coetzee, K., & Lombard, C. J. (2004). Comparative analysis of pregnancy rates after the transfer of early dividing embryos versus slower dividing embryos. Human Reproduction, 19(5), 1155-1162. Buttram Jr, V. C., & Reiter, R. C. (1981). Uterine leiomyomata: etiology, symptomatology, and management. Fertility and sterility, 36(4), 433. Kolankaya, A., & Arici, A. (2006). Myomas and assisted reproductive technologies: when and how to act?. Obstetrics and gynecology clinics of North America, 33(1), 145-152. Ramzy, A. M., Sattar, M., Amin, Y., Mansour, R. T., Serour, G. I., & Aboulghar, M. A. (1998). Uterine myomata and outcome of assisted reproduction. Human Reproduction, 13(1), 198-202 Eldar-Geva T, Meagher S, Healy DL, et al. Effect of intramural, subserosal, and submucosal uterine fibroids on the outcome of assisted reproductive technology treatment. Fertil Steril 1998;70(4):687 – 91. Vanderpump, M. P., & Tunbridge, W. M. G. (2005). The epidemiology of thyroid diseases. Werner and Ingbar's the thyroid: a fundamental and clinical text, 398-406.
score 12,131701